A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

Overview of attention for article published in Breast cancer targets and therapy, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 322)
High Attention Score compared to outputs of the same age (96th percentile)

Mentioned by

news: 10 news outlets
blogs: 1 blog
twitter: 6 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 12 Mendeley

Summary News Blogs X Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Dove Medical Press (NZ) Ltd, 22 Mar 2018

Breast tumor growth could be effectively controlled by simultaneous targeting of mtp53 protein and tumor... Breast tumor growth…